… stable disease, with tumor shrinkage observed in patients with thymic carcinoma, neuroendocrine renal carcinoma, mesothelioma, and non-clear ce…
All extracted diseases
Showing 1,081–1,140 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Articles mentioning diseases
23,712 articles · page 556 of 1976…everse tumor hypoxia in preclinical models and in patients with Glioblastoma Multiforme. We hypothesized, that reversing hypoxia with NanO2 will change…
…for patients (pts) with advanced treatment-naïve or -refractory basal cell carcinoma (BCC). Annals of Oncology 33:S922-S923.Deutsch JS, Lai J, Schen…
…-9, and TBil as independent predictors of mortality in advanced BTC patients receiving immuno-chemotherapy. The iDREM-BTC model dem…
…tember 2021-June 2023. Sera from 31 locally advanced/metastatic NSCLC patients, eligible for anti-PD-1/PD-L1 or combined chemoimmunot…
…tat, in different ICB-refractory murine tumor models, including CT26 (colorectal) and MOC-1 (HPV16 neg head and neck).Methods Mice r…
…ave significantly improved treatment outcomes for patients with non-Hodgkin lymphoma. However, patients with aggressive disease experience high refr…
…n PBMC.Methods Patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) were randomized to receive a heterologous prime-boost r…
…ghlighting FASN as a therapeutic target to sensitize irradiated glioblastoma to immunotherapy.Ethics Approval Animal studies were approved b…
… V12.6) to obtain expression data of the β6 integrin across The Cancer Genome Atlas (TCGA).Results High expression of β6 integrin mRNA…
…o-IO treatment of patients with advanced or metastatic squamous NSCLC without molecular alterations.…